«MediGene AG

Below is an extended MediGene AG patents listing. Click here to return to the MediGene AG main Biocorporate entry.

MediGene AG Patents :
US Patent No.	Title
7252997	Structural protein of adeno-associated virus with modified antigenicity, its production and its use
6207453	Recombinant AAV vector-based transduction system and use of same
6294370	System for the production of AAV vectors
6352696	Papillomavirus truncated L1 protein and fusion protein constructs
6440742	Recombinant AAV vector-based transduction system and use of same
6448074	Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells
6479676	OxiranEcarboxylic acids for the treatment of diabetes
6562351	Papilloma truncated L1 protein and fusion protein constructs
6649167	Papillomavirus truncated L1 protein and fusion protein constructs
7001765	Adeno-associated virus vector for boosting immunogenicity of cells
7182947	Papillomavirus truncated L1 protein and fusion protein constructs
6171597	Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.